BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 12170286)

  • 21. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in hereditary hemochromatosis.
    Franchini M; Veneri D
    Ann Hematol; 2005 Jun; 84(6):347-52. PubMed ID: 15747119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene.
    Pietrangelo A; Montosi G; Totaro A; Garuti C; Conte D; Cassanelli S; Fraquelli M; Sardini C; Vasta F; Gasparini P
    N Engl J Med; 1999 Sep; 341(10):725-32. PubMed ID: 10471458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles.
    Sham RL; Raubertas RF; Braggins C; Cappuccio J; Gallagher M; Phatak PD
    Blood; 2000 Dec; 96(12):3707-11. PubMed ID: 11090050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hereditary hemochromatosis].
    Niederau C
    Internist (Berl); 2003 Feb; 44(2):191-205; quiz 206-7. PubMed ID: 12674739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary hemochromatosis: molecular diagnosis and effect of treatment].
    Szczeklik W; Dropiński J; Dziedzina S; Szułdrzyński K; Biesiada G; Mach T; Sanak M
    Pol Arch Med Wewn; 2004 May; 111(5):593-6. PubMed ID: 15508811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The usefulness of the detection of Cys282Tyr and His63Asp mutations in the diagnosis of hereditary hemochromatosis].
    Moreno L; Vallcorba P; Boixeda D; Cabello P; Bermejo F; San Román C
    Rev Clin Esp; 1999 Oct; 199(10):632-6. PubMed ID: 10589245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary.
    Andrikovics H; Kalmár L; Bors A; Fandl B; Petri I; Kalász L; Tordai A
    Blood Cells Mol Dis; 2001; 27(1):334-41. PubMed ID: 11358395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease.
    Beutler E; Felitti V; Ho NJ; Gelbart T
    Acta Haematol; 2002; 107(3):145-9. PubMed ID: 11978935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hereditary hemochromatosis HFE: regulatory and economic aspects of diagnosis and medical management].
    Ropert-Bouchet M; Fajardy I; Michel H
    Ann Biol Clin (Paris); 2012; 70(4):405-11. PubMed ID: 22796612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.
    Scotet V; Le Gac G; Mérour MC; Mercier AY; Chanu B; Ka C; Mura C; Nousbaum JB; Férec C
    BMC Med Genet; 2005 Jun; 6():24. PubMed ID: 15929798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.